U.S. Infrastructure Stock News

In March 2026, Harmonic unveiled major upgrades to its sports streaming and XOS media processing platforms and expanded its cOS-powered fiber-on-demand deployment with Taiwanese operator KBRO to support multi-gigabit broadband and converged DOCSIS–fiber networks. Together, these product advances and the KBRO rollout highlight Harmonic’s push to tie software-driven innovation directly to operator monetization, cost efficiency and flexible network evolution across broadband and live sports...

In March 2026, Ascendis Pharma reported positive new data for its TransCon portfolio, including Week 52 Phase 2 results for TransCon hGH in Turner syndrome and two-year ApproaCH Trial outcomes for TransCon CNP in achondroplasia, while also adding former BioMarin CEO Jean‑Jacques Bienaimé to its board as a non‑executive director. The combination of once‑weekly therapies showing efficacy and safety comparable to existing daily standards, plus experienced rare‑disease leadership, highlights...

Shopify (SHOP) is back in focus after launching its Agentic Storefront, a feature that lets merchants sell directly through AI platforms like ChatGPT, Microsoft Copilot, and Google Search AI mode. See our latest analysis for Shopify. At a share price of US$111.85, Shopify has seen a 31.7% 90 day share price decline and a weaker recent stretch despite a 17.1% 1 year total shareholder return and a very strong 3 year total shareholder return of 134.6%. This suggests that long term holders have...

Over the last 7 days, the market has dropped 1.9%, although it is up 15% over the past year, with earnings forecast to grow by 15% annually. While penny stocks might seem like a nod to bygone trading days, they still offer relevant opportunities for growth when tied to companies with strong financials. This article explores three such penny stocks that stand out for their potential and financial robustness in today's market landscape.

Chewy, Inc. has already reported fourth-quarter 2025 and full-year 2025 results, with Q4 sales of US$3,264.7 million and net income of US$39.2 million, and full-year sales of US$12.60 billion alongside net income of US$222.8 million. Alongside the results, management highlighted the growing role of higher-margin areas like Chewy Vet Care and planned AI-driven efficiencies, which they expect to meaningfully lower customer service costs over the next two years. Next, we’ll look at how Chewy’s...

Renewed doubts over a potential US Iran peace deal have pushed investors back into oil and gas stocks, with NextDecade (NEXT) gaining attention after a reported 11.04% move during a three day rally. See our latest analysis for NextDecade. Beyond the latest move, NextDecade’s recent price action has been strong, with a 7 day share price return of 12.76% and a 30 day share price return of 50.83%. The 1 year total shareholder return of 4.50% contrasts with a much larger 5 year total shareholder...

Over the last 7 days, the United States market has experienced a 1.9% drop, yet it remains up by 15% over the past year with earnings projected to grow annually by the same percentage. In this dynamic environment, identifying stocks that are not only resilient but also positioned for growth can be crucial for investors seeking opportunities beyond well-trodden paths.

Over the last 7 days, the United States market has experienced a 1.9% decline, yet it remains up by 15% over the past year with annual earnings growth forecasted at 15%. In this dynamic environment, identifying dividend stocks that offer reliable income and potential for capital appreciation can be an effective strategy for investors seeking stability and growth.

Earlier in March 2026, Alarm.com announced new AI-powered platform enhancements and an expanded hardware lineup at ISC West, including AI Video Event Search, AI Access Assist, upgraded analytics, and several next-generation camera series spanning residential and commercial use cases. The breadth of these AI and hardware upgrades, alongside deeper integrations like CHeKT and new services such as Fire Communicator and Mobile Security Trailers, underscores Alarm.com’s push to make its unified...

What stands out about Weyerhaeuser right now Weyerhaeuser (WY) continues to trade with recent returns that differ meaningfully across time frames, with a positive move over the past week but negative performance over the past month and past 3 months. See our latest analysis for Weyerhaeuser. At a share price of $23.86, Weyerhaeuser sits roughly flat year to date, with a modest 7 day share price return of 3.02%. However, its 1 year total shareholder return decline of 15.67% points to fading...

In March 2026, Masco Corporation was removed from the FTSE All-World Index (USD), a widely followed global benchmark that many index-tracking funds use to structure their holdings. This exclusion can trigger mechanical selling by passive investors and prompt active investors to reassess Masco’s visibility and role in globally diversified portfolios. Next, we’ll examine how Masco’s removal from the FTSE All-World Index could affect its investment narrative built around cash returns and...

AvePoint (AVPT) has drawn investor attention after recent trading left the shares about 32% below their level of the past 3 months and roughly 12% lower over the past month, inviting a closer look at its cloud data management business. See our latest analysis for AvePoint. AvePoint's recent pullback, including a 7 day share price return of negative 7.8% and year to date share price return of negative 28.6%, sits against a three year total shareholder return of 128.0%. This suggests long term...

Cencora (COR) has drawn attention after recent trading, with the share price at US$312.45 and negative returns over the past week, month and past 3 months, prompting fresh questions about valuation and business momentum. See our latest analysis for Cencora. The recent 30 day share price return of negative 16.0% and year to date share price return of negative 7.8% contrast with a 1 year total shareholder return of 13.2% and 5 year total shareholder return of 181.5%. This points to fading short...

ProFrac Holding Corp. recently reported its Q4 and full-year 2025 results, showing profitability that exceeded expectations despite a softer North American completions market and announcing a cost optimization plan targeting US$100 million in annualized savings by mid-2026. This combination of resilient profitability and an aggressive efficiency program highlights how ProFrac’s vertically integrated model can support margins even when industry activity weakens. We’ll now examine how the new...

In March 2026, Lockheed Martin and the Department of War announced a framework agreement to accelerate and ultimately quadruple production capacity for Precision Strike Missiles, building on a prior US$4.94 billion U.S. Army contract and enabling potential multi-year deals of up to seven years pending future congressional approval. The framework not only expands advanced missile output but also signals a deeper, longer-term production commitment that could reshape Lockheed Martin’s...

Insulet Corporation recently appointed Mike Panos as Executive Vice President and Chief Commercial Officer, placing him in charge of the company’s global commercial organization under President and CEO Ashley McEvoy and adding him to the Executive Leadership Team. Panos’ three decades of medical technology commercial leadership at Stryker, including responsibility for large global businesses, suggests Insulet is prioritizing disciplined commercial execution and talent development as it seeks...

Whirlpool (WHR) is back in focus after KitchenAid introduced the Artisan Plus Tilt-Head Stand Mixer, described as its biggest upgrade since 1955. The new model targets premium home bakers with enhanced control and visibility features. See our latest analysis for Whirlpool. Despite the renewed attention from KitchenAid’s Artisan Plus launch, Whirlpool’s recent momentum has been weak, with a 30-day share price return of 24.13% decline and a 1-year total shareholder return of 39.03% decline...

Bausch + Lomb recently reported positive 24‑month results from its pivotal U.S. trial of the implant‑free ELIOS excimer laser system for treating mild to moderate open‑angle glaucoma during cataract surgery, showing meaningful intraocular pressure reduction and a safety profile comparable to cataract surgery alone. The strong proportion of patients achieving at least a 20% drop in unmedicated intraocular pressure and remaining medication‑free for nearly two years highlights how ELIOS could...

On 23 March 2026, Dimensional Fund Advisors announced it had appointed State Street as end-to-end service provider for its first-of-its-kind U.S. ETF share class structure under new SEC exemptive relief, while State Street also added former top U.S. intelligence official Susan Gordon to its Board. This combination of pioneering ETF servicing work and enhanced board-level expertise in technology, cybersecurity and geopolitical risk could strengthen State Street’s role as a global...

On March 26, 2026, Archer-Daniels-Midland filed a definitive proxy statement urging shareholders to vote against a pesticide-use reporting proposal tied to its regenerative agriculture disclosures, while the EPA recently raised required biofuel blending levels in gasoline and diesel, supporting demand for crop-based feedstocks. This combination of increased regulatory support for biofuels and investor pressure on pesticide transparency highlights how policy and shareholder scrutiny are...

Old Second Bancorp overview and recent share performance Old Second Bancorp (OSBC) has drawn investor attention after recent share price moves, with the stock closing at $19.57. Returns are mixed, with a 0.7% decline over the past week and modest month performance. See our latest analysis for Old Second Bancorp. Recent trading has been relatively muted, with slight share price softness over the past month but a stronger 1 year total shareholder return of 19.34%, indicating that longer term...

In recent months, Janus Henderson’s Forty Fund highlighted Madrigal Pharmaceuticals’ success with Rezdiffra, the first FDA-approved MASH therapy, while the company also signed a global licensing deal with Suzhou Ribo Life Science and Ribocure for six preclinical siRNA programs targeting metabolic liver disease. Together, strong early Rezdiffra adoption and an expanded siRNA pipeline suggest Madrigal is moving from a single-product story toward a broader MASH-focused franchise. Next, we’ll...

Earlier this month, Vaxcyte announced it had fully enrolled its OPUS-1 and OPUS-2 Phase 3 trials of VAX-31, a 31-valent pneumococcal conjugate vaccine for adults, and recently published positive Phase 1/2 VAX-31 data in The Lancet Infectious Diseases. These milestones, together with FDA-aligned Phase 3 designs intended to support a future Biologics License Application, underscore VAX-31’s potential to broaden pneumococcal disease coverage versus existing adult vaccines. We’ll now examine how...

Why Dauch (DCH) is on investors' radar today Dauch (DCH) has drawn attention after its recent rebrand from American Axle & Manufacturing Holdings, Inc., a shift that spotlights its role in driveline and metal forming technologies across electric, hybrid, and internal combustion vehicles. See our latest analysis for Dauch. Despite the recent name change, the short term picture has been softer, with a 30 day share price return of 15% and a year to date share price return of 13.6%, while the 1...